These findings illustrate the safety and efficacy for WBC application in a variety of hard-to-to-heal wounds such as DFUs, vascular ulcers, pressure injuries, and non-healing surgical site infections. Based on wound size reduction results, it is suggested that the application of WBC technology changes the chronic nature of the hard-to-heal wound into an acute wound healing trajectory significantly faster than what is suggested in the literature.
Based on the findings in the observational pilot study, it is recommended that healthcare systems and insurance companies use WBC in hard-to-heal wounds to achieve complete healing and, thus, reduce the ongoing burden to the patient and associated costs.
To learn more, read the full publication HERE
To learn more about ActiGraft and how it can benefit your practice visit: https://reddressmedical.com/actigraft
|